X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (205) 205
oncology (193) 193
index medicus (179) 179
melanoma (130) 130
immunotherapy (107) 107
female (106) 106
male (103) 103
ipilimumab (99) 99
cancer (95) 95
middle aged (92) 92
melanoma - drug therapy (83) 83
aged (81) 81
metastatic melanoma (81) 81
adult (66) 66
melanoma - pathology (59) 59
immunology (57) 57
article (56) 56
antibodies, monoclonal - therapeutic use (55) 55
nivolumab (51) 51
treatment outcome (50) 50
tumors (45) 45
antineoplastic agents - therapeutic use (43) 43
care and treatment (42) 42
aged, 80 and over (41) 41
melanoma - immunology (41) 41
metastasis (41) 41
antibodies, monoclonal - adverse effects (39) 39
melanoma - therapy (38) 38
survival (38) 38
animals (35) 35
safety (35) 35
therapy (35) 35
skin neoplasms - drug therapy (32) 32
skin neoplasms - pathology (32) 32
cell lung-cancer (31) 31
neoplasm staging (31) 31
pembrolizumab (31) 31
blockade (30) 30
pd-1 (30) 30
research (30) 30
expression (29) 29
antibodies, monoclonal - administration & dosage (27) 27
chemotherapy (26) 26
medicine, general & internal (26) 26
melanoma - genetics (26) 26
melanoma - mortality (26) 26
melanoma - secondary (26) 26
patients (26) 26
mutation (25) 25
abridged index medicus (24) 24
disease-free survival (24) 24
programmed cell death 1 receptor - antagonists & inhibitors (24) 24
antigens (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
clinical trials (22) 22
drug therapy (22) 22
health aspects (22) 22
kaplan-meier estimate (22) 22
trial (22) 22
antineoplastic agents - adverse effects (21) 21
lymphocytes (21) 21
open-label (21) 21
solid tumors (21) 21
antibody (20) 20
ctla-4 blockade (20) 20
mice (20) 20
neoplasms - immunology (20) 20
metastases (19) 19
t-cells (19) 19
adverse events (18) 18
analysis (18) 18
retrospective studies (18) 18
antibodies (17) 17
cell line, tumor (17) 17
ctla-4 (17) 17
disease progression (17) 17
malignant-melanoma (17) 17
neoplasm metastasis (17) 17
neoplasms - drug therapy (17) 17
usage (17) 17
vemurafenib (17) 17
ctla-4 antigen - antagonists & inhibitors (16) 16
cytotoxicity (16) 16
immune checkpoint (16) 16
medicine, research & experimental (16) 16
untreated melanoma (16) 16
advanced melanoma (15) 15
apoptosis (15) 15
dose-response relationship, drug (15) 15
immunotherapy - methods (15) 15
lymphocytes t (15) 15
melanoma - metabolism (15) 15
multicenter (15) 15
neoplasms - therapy (15) 15
phase-ii (15) 15
prognosis (15) 15
responses (15) 15
cancer therapies (14) 14
cell biology (14) 14
immunohistochemistry (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 09/2015, Volume 373, Issue 13, pp. 1270 - 1271
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 13, pp. 1290 - 1290
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma Original Article, N Engl J Med 2010:363;711-723. The disclosure statement (page 721)... 
MEDICINE, GENERAL & INTERNAL
Journal Article
Cell, ISSN 0092-8674, 11/2017, Volume 171, Issue 4, pp. 934 - 949.e16
Journal Article
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, ISSN 0889-8588, 06/2014, Volume 28, Issue 3, pp. XIII - XIV
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1345 - 1356
Journal Article